Today, SkinCeuticals adds Azelaic Acid to the roster of Custom D.O.S.E active booster blends. Azelaic acid has been shown to offer a wide variety of benefits for the skin, including improvement in the appearance of skin discoloration and skin clarity. Available in Custom D.O.S.E formulations at 5% and 12%, azelaic acid, is elevated by its ability to simultaneously improve clarity, uneven skin tone, and reduce the appearance of imperfections. Our 8-week clinical study demonstrated 42% improvement in skin clarity1.
"Azelaic acid is a great addition to Custom D.O.S.E, it's a true multi-tasker," says Dr. Sarah Sawyer, SkinCeuticals Partner Physician. "Azelaic acid can be used for gentle correction of imperfections and helps overall skin clarity and uneven skin tone."
When it comes to improving clarity, multi-targeting through different ingredients and pathways is often encouraged. Azelaic acid allows for 28 new and unique combinations bringing the total possible Custom D.O.S.E formula combinations to 77.
This fall, CUSTOM D.O.S.E azelaic acid will be available in select U.S. physician offices nationwide. For more information, visit www.skinceuticals.com/customdose.
ABOUT SKINCEUTICALS
Founded in Dallas, TX in 1997, SkinCeuticals discovers, develops and delivers an advanced line of scientifically backed cosmeceutical treatments. As leaders in antioxidant and sun protection technology, SkinCeuticals products have been shown to dramatically improve skin health by protecting skin from environmental damage and visibly improving skin clarity, tone, and texture to minimize the appearance of fine lines and wrinkles. For more information, visit the brand on Facebook, Twitter or Instagram, or at www.skinceuticals.com.
1Protocol: 8 week study, 52 participants, EB369 applied twice daily with Gentle Cleanser, Daily Moisture moisturizer and Light Moisture UV Defense
CONTACT
[email protected]
SOURCE SkinCeuticals
Related Links
October 01, 2020 at 10:15PM
https://ift.tt/3jn9jYo
SkinCeuticals Expands Custom DOSE With Azelaic Acid Booster Blend - PRNewswire
https://ift.tt/2DVP6sH
No comments:
Post a Comment